geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis


, : A double-blind comparison of balsalazide, 6.75 g, and sulfasalazine, 3 g, as sole therapy in the management of ulcerative colitis. Alimentary Pharmacology & Therapeutics 16(1): 69-77, January

Background: Sulfasalazine is accepted therapy for active ulcerative colitis, but side-effects and intolerance are common. Balsalazide is an azo-bonded pro-drug which also releases 5-aminosalicylic acid into the colon, but uses an inert carrier molecule. Aim: To compare the safety and efficacy of sulfasalazine, 3 g, with balsalazide, 6.75 g, in the initial daily treatment of mild to moderate ulcerative colitis. Methods: A randomized, multicentre, double-blind, parallel group study was performed, with a treatment duration of 8 weeks. Patients on previous maintenance treatment were excluded. The trial medication was the sole treatment for the colitis. Efficacy was assessed by patient diaries, symptom assessment, sigmoidoscopic appearance and histology. Results: Fifty patients were recruited: 26 allocated to the balsalazide group and 24 to the sulfasalazine group. More patients withdrew due to adverse events in the sulfasalazine group (nine patients vs. one patient in the balsalazide group, P=0.004). Improvement occurred in both groups, with a tendency to a faster response with balsalazide. Of the patients taking balsalazide, 61% achieved clinical and sigmoidoscopic remission. Conclusions: Balsalazide, 6.75 g, is effective as the sole treatment for patients with mild to moderately active ulcerative colitis, with significantly fewer withdrawals due to side-effects than in a similar group of patients taking sulfasalazine, 3 g.

US$19.90

PMID: 11856080

DOI: 10.1046/j.1365-2036.2002.01151.x


Other references

Jerrold, L., 2011: Litigation and legislation. Working for another. American Journal of Orthodontics and Dentofacial Orthopedics 139(5): 708-710

Gray, P.J., 1991: Aerosols causing ocular trauma. Bmj 302(6770): 238-238

Richmond, J.P.; Devlin, R., 2003: Nurses' knowledge of prevention and management of constipation. Constipation is often a preventable problem in health care; therefore health professionals must have the appropriate knowledge to help patients prevent this common complaint occurring. The purpose of this study was to assess nurses' knowledge...

Hof, H.; Oberdorfer, K.; Singer, S.; Holfelder, M.; Fahr, A., 2012: Pneumococcal sepsis in aged patients - implications for the vaccination of seniors against pneumococci. In the years 2005-2010 pneumococci were isolated in the Limbach laboratory/Heidelberg from blood cultures of 1,085 patients. Obviously, older patients are more prone to these bacteria, since 66 % of the patients were older than 60 years. All iso...

González-Duarte, R.José.; Cázares-Ordoñez, V.; Díaz, L.; Ortíz, Víctor.; Larrea, F.; Avila, E., 2016: The expression of RNA helicase DDX5 is transcriptionally upregulated by calcitriol through a vitamin D response element in the proximal promoter in SiHa cervical cells. The DEAD box RNA helicase DDX5 is a multifunctional protein involved in the regulatory events of gene expression. Herein, we presented evidence indicating that DDX5 is transcriptionally upregulated by calcitriol, the hormonal form of vitamin D3. I...

Miyagawa, S.; Saito, A.; Sakaguchi, T.; Yoshikawa, Y.; Yamauchi, T.; Imanishi, Y.; Kawaguchi, N.; Teramoto, N.; Matsuura, N.; Iida, H.; Shimizu, T.; Okano, T.; Sawa, Y., 2010: Impaired myocardium regeneration with skeletal cell sheets--a preclinical trial for tissue-engineered regeneration therapy. We hypothesized that autologous skeletal cell (SC) sheets regenerate the infract myocardium in porcine heart as a preclinical trial. The impaired heart was created by implantation of ameroid constrictor on left anterior descending for 4 weeks. SCs...

Gardner, W.A.; Taber, E., 1963: The demonstration on non-steroid gonadal inhibiting substance elaborated by the ovary of the brown Leghorn. Anat Rec 145(2): 231

Saurin, J-Christophe.; Maunoury, V.; Lapalus, M-Georges.; Cellier, C.; Delvaux, M.; Favre, O.; Gay, Gérard.; Heresbach, D., 2008: International consensus in Paris, 2006, on the indications and use of the endoscopic videocapsule test. Report of the SFED Capsule Commission. Following the 4th International Conference on Capsule Endoscopy (ICCE, Miami 2005), the main indications for videocapsule endoscopy (VCE) were reviewed. The consensus guidelines were published in Endoscopy in 2005. These propositions for VCE were...

Bertoli, A.; Moran, O.; Conti, F., 1994: Activation and deactivation properties of rat brain K+ channels of the Shaker-related subfamily. We studied the activation properties of members of the Shaker-related subfamily of voltage-gated K+ channels cloned from rat brain and expressed in Xenopus oocytes. We find that Kv1.1, Kv1.4, Kv1.5, and Kv1.6 have similar activation and deactivati...

Smith, D.M.A.; Raugei, S.; Squier, T.C., 2014: Modulation of active site electronic structure by the protein matrix to control [NiFe] hydrogenase reactivity. Control of the reactivity of the nickel center of the [NiFe] hydrogenase and other metalloproteins commonly involves outer coordination sphere ligands that act to modify the geometry and physical properties of the active site metal centers. We car...